Research Overview
The objective of this study is to assess the efficacy of oral methotrimeprazine versus oral haloperidol in patients with cancer and nausea not related to anticancer treatment. Subjects who meet the criteria will be enrolled in the study for a period of three days. Participants will be evaluated on a daily basis and dose escalation will occur at 24 and 48 hours, if the NRS nausea scale does not improve by two points, dependant on clinician evaluation. A follow-up of four weeks will occur post study.
Key Contact
Palliative Care Clinical Trials Team
Phone: 03 9416 0000
Project Team
Palliative Care Clinical Trials Team, Centre for Palliative Care, St Vincent’s Hospital Melbourne.
- A/Prof Jennifer Philip
- Dr Jennifer Weil
- Sally Kidd
- Rosetta Hart
Funding Source
The Palliative Care Clinical Studies Collaborative (PaCCSC)
Key Publications
Pending